Data / Drug companies / Simvastatin
Simvastatin: 32 companies and 160 products in the FDA NDC directory
Simvastatin is listed in the FDA National Drug Code Directory by 32 companies, with 160 products in commercial distribution. 157 of the products (98.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated, and the newest product started marketing on May 21, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 32
- Products
- 160
- Generic (ANDA) products
- 157 (98.1%)
- Application numbers
- 7
- Routes
- Oral
- Brand names
- Zocor
- openFDA record search
- api.fda.gov
Companies that list simvastatin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 24 | tablet, film coated | Generic drugs (ANDA) | February 19, 2016 |
| NuCare Pharmaceuticals,Inc. | 10 | tablet, film coated | Generic drugs (ANDA) | February 19, 2016 |
| Aphena Pharma Solutions - Tennessee, LLC | 9 | tablet, film coated | Generic drugs (ANDA) | December 17, 2015 |
| Bryant Ranch Prepack | 9 | tablet, film coated | Generic drugs (ANDA) | April 14, 2025 |
| Northwind Health Company, LLC | 7 | tablet, film coated | Generic drugs (ANDA) | March 29, 2023 |
| Remedyrepack Inc. | 6 | tablet, film coated | Generic drugs (ANDA) | June 14, 2024 |
| Accord Healthcare Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | September 12, 2014 |
| Aurobindo Pharma Limited | 5 | tablet, film coated | Generic drugs (ANDA) | December 20, 2006 |
| Biocon Pharma Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | December 17, 2015 |
| Bryant Ranch Prepack | 5 | tablet, film coated | Generic drugs (ANDA) | September 12, 2014 |
| Camber Pharmaceuticals, Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | December 9, 2014 |
| Golden State Medical Supply, Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | December 20, 2006 |
| Lupin Pharmaceuticals, Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | February 19, 2016 |
| NorthStar Rx LLC | 5 | tablet, film coated | Generic drugs (ANDA) | December 20, 2006 |
| Quallent Pharmaceuticals Health LLC | 5 | tablet, film coated | Generic drugs (ANDA) | May 26, 2022 |
| XLCare Pharmaceuticals, Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | January 21, 2026 |
| Proficient Rx LP | 4 | tablet, film coated | Generic drugs (ANDA) | December 2, 2015 |
| Westminster Pharmaceuticals, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | April 14, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | December 20, 2006 |
| Coupler LLC | 3 | tablet, film coated | Generic drugs (ANDA) | May 21, 2026 |
| Direct_Rx | 3 | tablet, film coated | Generic drugs (ANDA) | March 24, 2023 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 3 | tablet, film coated | Generic drugs (ANDA) | December 2, 2015 |
| Organon LLC | 3 | tablet, film coated | New drug applications (NDA) | June 1, 2021 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 19, 2016 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 26, 2008 |
| Preferred Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | March 29, 2023 |
| Proficient Rx LP | 3 | tablet, film coated | Generic drugs (ANDA) | February 26, 2008 |
| QPharma, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 19, 2016 |
| St. Mary's Medical Park Pharmacy | 3 | tablet, film coated | Generic drugs (ANDA) | April 20, 2023 |
| American Health Packaging | 2 | tablet, film coated | Generic drugs (ANDA) | September 8, 2011 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | June 8, 2016 |
| Cardinal Health 107, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | May 2, 2011 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 160 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 157 | 98.1% |
| New drug applications (NDA) | 3 | 1.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| HMG-CoA Reductase Inhibitor | 160 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.